According to Johns Hopkins Bloomberg School of Public Health, clinical medical intervention trials that companies use to support FDA drug approvals cost approximately $19 million per trial. While this may only be one percent of the total cost of developing a new drug or other medical intervention, it means creating a low-quality clinical trial — or getting low-quality data from the endeavor — can... Read More